Epstein Secrets

From: "Jeffrey E." <[email protected]> To: Subject: Fwd: Alzhe

i wanted to talk to him about Forwarded message From: Date: Sat, Apr 8, 2017 at 9:17 AM Subject: Fwd: Alzheimer's R&D updates - March 2017 To: Jeffrey Epstein <[email protected]> Begin forwarded message: From:- > Datil.8 2017 at 3:38:14 AM EDT To: < > Subject: FW: Alzheimer's R&D updates - March

Alzheimer's R&D updates - March 2017 To: Jeffrey Epstein <[email protected]> Begin forwarded message:

From: "Jeffrey E." <[email protected]> To: Subject: Fwd: A

asian, non- US populations, this type of approach could prove to be very useful for screening, stratifying, and enrolling subjects for drug trials. Desikan RS, Fan CC, Wang Y, Schork Al, Cabral HJ, Cupples LA, Thompson WK, Besser L, Kukull WA, Holland D, Chen CH, Brewer 1B, Karow DS, Kauppi K, Witoelar A,

15:25:52 +0000 Good morning - well received, thank you very much. Executive Assistant to Ronald S. Lauder RSL Management Corporation T F From: Jeffrey Epstein Date: Saturday, April 8, 2017 at 9:30 AM Subject: Fwd: Alzheimer's R&D updates - March 2017 Morning! please forward below to Ronald. ... tell him

R&D updates - March 2017 Morning! please forward below to Ronald. ... tell him Gates has decided to spend some money on alzhhiemers, that is what Jeffrey wanted to talk to him about Thanks, Forwarded message From: Date: Sat, Apr 8, 2017 at 9:17 AM Subject: Fwd: Alzheimer's R&D updates - March 201

RSL Management Corporation T F From: Jeffrey Epstein Date: Saturday, April 8, 2017 at 9:30 AM Subjec

populations, this type of approach could prove to be very useful for screening, stratifying, and enrolling subjects for drug trials. EFTA00449356 Desikan RS, Fan CC, Wang Y, Schork Al, Cabral HI, Cupples LA, Thompson WK, Besser L, Kukull WA, Holland D, Chen CH, Brewer JB, Karow DS, Kauppi K, Witoelar A,

at, 08 Apr 2017 13:30:11 +0000 Morning! please forward below to.. ... tell him Gates has decided to spend some money on alzhhiemers, that is what Jeffrey wanted to talk to him about Thanks, Forwarded message From: Date: Sat, Apr 8, 2017 at 9:17 AM Subject: Fwd: Alzheimer's R&D updates - March 201

casian, non-US populations, this type of approach could prove to be very useful for screening, stratifying, and enrolling subjects for drug trials. Desikan RS, Fan CC, Wang Y, Schork Al, Cabral HI, Cupples LA, Thompson WK, Besser L, Kukull WA, Holland D, Chen CH, Brewer JB, Karow DS, Kauppi K, Witoelar A,